ERBB2 and breast cancer: However, few studies investigated the differences in clinical characteristics and prognosis between HER2‐low and HER2‐zero BC among Chinese HER2‐negative BC and their stratified differences by hormone receptor (HR), while fewer studies investigated their differences in epidemiological factors and genetic susceptibility.